These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 731121)

  • 41. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 43. Imipramine and methylphenidate in hyperactive children.
    Werry JS; Aman MG; Diamond E
    J Child Psychol Psychiatry; 1980 Jan; 21(1):27-35. PubMed ID: 7358801
    [No Abstract]   [Full Text] [Related]  

  • 44. The learning-disabled or hyperactive child: diagnosis and treatment.
    Sulzbacher SI
    JAMA; 1975 Dec; 234(9):938-41. PubMed ID: 1242491
    [No Abstract]   [Full Text] [Related]  

  • 45. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.
    Molina-Carballo A; Naranjo-Gómez A; Uberos J; Justicia-Martínez F; Ruiz-Ramos MJ; Cubero-Millán I; Contreras-Chova F; Augustin-Morales MD; Khaldy-Belkadi H; Muñoz-Hoyos A
    J Psychiatr Res; 2013 Mar; 47(3):377-83. PubMed ID: 23088865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth deficits in children treated with desipramine: a controlled study.
    Spencer T; Biederman J; Wright V; Danon M
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):235-43. PubMed ID: 1564024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of long-term stimulant medication on the growth and body composition of hyperactive children [proceedings].
    McNutt BA; Boileau RA; Cohen MN
    Psychopharmacol Bull; 1977 Apr; 13(2):36-8. PubMed ID: 323908
    [No Abstract]   [Full Text] [Related]  

  • 48. Methylphenidate-related growth impairment.
    Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
    J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis.
    Butter HJ; Lapierre Y; Firestone P; Blank A
    J Clin Psychopharmacol; 1983 Aug; 3(4):226-30. PubMed ID: 6309918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
    Sund AM; Zeiner P
    Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 53. Minimal brain dysfunction and methylphenidate.
    Schwartz ML; Pizzo SV; McKee PA
    N Engl J Med; 1971 Jul; 285(5):293. PubMed ID: 5090403
    [No Abstract]   [Full Text] [Related]  

  • 54. Methylphenidate and caffeine in the treatment of children with minimal brain dysfunction.
    Garfinkel BD; Webster CD; Sloman L
    Am J Psychiatry; 1975 Jul; 132(7):723-8. PubMed ID: 1094842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.
    Robison LM; Sclar DA; Skaer TL; Galin RS
    Clin Pediatr (Phila); 1999 Apr; 38(4):209-17. PubMed ID: 10326176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood pressure and pulse changes in hyperactive children treated with imipramine and methylphenidate.
    Greenberg LM; Yellin AM
    Am J Psychiatry; 1975 Dec; 132(12):1325-6. PubMed ID: 1106218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hyperactive child.
    Chapel JL
    Mo Med; 1973 Nov; 70(11):768-74. PubMed ID: 4753031
    [No Abstract]   [Full Text] [Related]  

  • 60. Methylphenidate and minimal brain dysfunction.
    Cohn HD
    N Engl J Med; 1971 Nov; 285(20):1150. PubMed ID: 5095752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.